Generic Specialties, Inc., based in Orlando, FL, is a rapidly growing generic pharmaceutical company engaged in the manufacture, acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S. prescription drug market. We also export to Central and South American markets. Generic Specialties, markets a variety of products in multiple pack sizes, and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, warehousing, non-warehousing chain drugstores, and managed care providers. Through our group companies, we are a vertically integrated, manufacturer with the flexibility to develop and manufacture our products, both at our local plants within the U.S. and also in India.
Generic Specialties, products cover a number of therapeutic categories, including but not limited to: cardiovascular, metabolic disease, anti-infective and pain management. We mfg. Large volume parenterals, Small volume parenterals (Opthalmics), and various other catagoeries of prescription generics. The Company's business model utilizes a virtually integrated global supply network that leverages strategic outsourcing to US-FDA approved manufacturing and development organizations in both America & India.
The company owns a robust pipeline of multisource and high barrier products and will continue to introduce new generic products during the coming years as its pipeline matures through the regulatory approval cycle. The foundation and advantage of our business model is the integration of a professionally qualified technical team, latest state of the art manufacturing facilities, our own API plants, spread around in USA and India, strong commercial operations and sales team with a global supply chain network that provides access to low cost development, materials and manufacturing capacity.
We remain pro-active in regards to growing our business appropriately to fit the current competitive environment, while maintaining a focus on creating value with quality generic pharmaceuticals with strategic focus on the needs of U.S. health care system.
Our network provides dedicated services for research, development and commercial manufacturing, with built in materials and manufacturing cost efficiencies. The advantage of Generic Specialties, "virtual" business model is that it allows us to be efficient and flexible in business development while focusing on commercialization excellence and customer service.